Transition Therapeutics Company Profile (NASDAQ:TTHI)

About Transition Therapeutics

Transition Therapeutics logoTransition Therapeutics Inc. is a product-focused biopharmaceutical company. The Company's principal business activity is the researching and developing of therapeutic agents. The Company is developing therapeutics for central nervous system (CNS) and metabolic disease indications. The Company's technologies are focused on the treatment of agitation and aggression in Alzheimer's disease and diabetes. The Company's subsidiary, Transition Therapeutics Ireland Limited (Transition Ireland), is developing two drug candidates: neuropsychiatric candidate ELND005 and androgen deficiency candidate TT701. The Company's subsidiary, Waratah Pharmaceuticals Inc. (Waratah), is developing diabetes drug candidate TT401. The Company's other two entities provide development services in support of the clinical and non-clinical activities of Transition Ireland and Waratah.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TTHI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.49
  • 50 Day Moving Average: $1.59
  • 200 Day Moving Average: $1.10
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.01
  • P/E Growth: 0.00
  • Market Cap: $57.93M
  • Outstanding Shares: 38,878,000
  • Beta: 1.63
Additional Links:
Companies Related to Transition Therapeutics:

Analyst Ratings

Consensus Ratings for Transition Therapeutics (NASDAQ:TTHI) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.50 (0.67% upside)

Analysts' Ratings History for Transition Therapeutics (NASDAQ:TTHI)
Show:
DateFirmActionRatingPrice TargetDetails
5/14/2016Cowen and CompanyReiterated RatingHoldView Rating Details
4/19/2016Canaccord GenuityReiterated RatingHoldView Rating Details
2/11/2015HC WainwrightReiterated RatingBuy$10.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Transition Therapeutics (NASDAQ:TTHI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/15/2015Q415($0.39)($0.31)ViewN/AView Earnings Details
5/12/2015Q315($0.20)($0.11)ViewN/AView Earnings Details
2/10/2015($0.24)($0.38)ViewN/AView Earnings Details
11/12/2014Q312($0.18)($0.45)ViewN/AView Earnings Details
9/26/2014($0.28)($0.39)ViewN/AView Earnings Details
5/14/2014($0.07)($0.16)ViewN/AView Earnings Details
11/12/2013($0.11)($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Transition Therapeutics (NASDAQ:TTHI)
Current Year EPS Consensus Estimate: $-0.26 EPS
Next Year EPS Consensus Estimate: $-1.47 EPS

Dividends

Dividend History for Transition Therapeutics (NASDAQ:TTHI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Transition Therapeutics (NASDAQ:TTHI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Transition Therapeutics (NASDAQ:TTHI)
DateHeadline
finance.yahoo.com logoTransition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval … (NASDAQ:TTHI)
finance.yahoo.com - August 26 at 7:33 PM
streetinsider.com logoOPKO Health (OPK) Announces Transition Therapeutics (TTHI) Shareholder Approval of Proposed Acquisition (NASDAQ:TTHI)
www.streetinsider.com - August 26 at 10:49 AM
finance.yahoo.com logo8:53 am Transition Therapeutics shareholders approve merger with OPKO health (OPK (NASDAQ:TTHI)
finance.yahoo.com - August 26 at 10:49 AM
finance.yahoo.com logoTransition (TTHI) Stock Up on News of Acquisition by Opko (NASDAQ:TTHI)
finance.yahoo.com - July 1 at 8:59 AM
insidermonkey.com logoHere’s Why Traders Are Watching These Five Stocks Today (NASDAQ:TTHI)
www.insidermonkey.com - June 30 at 10:40 AM
News IconTransition Therapeutics Ord (NASDAQ:TTHI) Short Interest Decreased By 12.21% - Wall Street Hints and News (NASDAQ:TTHI)
hintsnewsnetwork.com - May 27 at 2:38 PM
News IconTransition Therapeutics, Inc. (TTHI) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:TTHI)
www.sharetrading.news - May 24 at 3:03 PM
tradecalls.org logoRevenue Update on Transition Therapeutics Inc (USA)(NASDAQ:TTHI) - Trade Calls (NASDAQ:TTHI)
www.tradecalls.org - May 20 at 2:47 PM
News IconPhil Kessel scores twice as Pittsburgh Penguins eliminate Washington Capitals with 4-3 victory in OT (NASDAQ:TTHI)
www.theprovince.com - May 12 at 9:19 AM
sg.finance.yahoo.com logoTransition Therapeutics posts 3Q loss (NASDAQ:TTHI)
sg.finance.yahoo.com - May 11 at 4:23 PM
finance.yahoo.com logoTransition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results (NASDAQ:TTHI)
finance.yahoo.com - May 11 at 4:01 PM
finance.yahoo.com logoTransition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST (NASDAQ:TTHI)
finance.yahoo.com - May 9 at 4:01 PM
News IconTransition Therapeutics Ord (NASDAQ:TTHI) Shorted Shares Decreased By 8.42% - B.O.D.Y Confidential (NASDAQ:TTHI)
www.bodyconfidential.com - April 29 at 9:32 AM
streetinsider.com logoTransition Therapeutics (TTHI) Commences Dosing in TT701 Phase 2 in Androgen Deficiency - StreetInsider.com (NASDAQ:TTHI)
www.streetinsider.com - April 26 at 9:48 AM
finance.yahoo.com logoTransition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701 (NASDAQ:TTHI)
finance.yahoo.com - April 25 at 4:01 PM
cchdailynews.com logoTransition Therapeutics Ord (NASDAQ:TTHI) Sellers Covered 8.42% of Their Shorts - CCH Daily News (NASDAQ:TTHI)
cchdailynews.com - April 24 at 8:49 AM
News IconLatest Analyst Ratings For Transition Therapeutics, Inc. (TTHI) - Share Trading News (NASDAQ:TTHI)
www.sharetrading.news - April 22 at 9:53 AM
News IconBroker Roundup For Transition Therapeutics, Inc. (TTHI) - Share Trading News (NASDAQ:TTHI)
www.sharetrading.news - April 21 at 9:56 AM
investors.com logoBiotech Stocks Inside Traders Spotlight: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) , Transition Therapeutics, Inc ... - WsNews 4investors (NASDAQ:TTHI)
www.wsnews4investors.com - April 19 at 10:17 AM
wallstrt24.com logoAstraZeneca plc (NYSE:AZN) & Transition Therapeutics (NASDAQ:TTHI) Hot Stock's Alert - Wall Street 24 (NASDAQ:TTHI)
wallstrt24.com - April 19 at 10:17 AM
News IconActive Stocks Need to Consider- M&T Bank (NYSE:MTB), Transition Therapeutics. (NASDAQ:TTHI), GlaxoSmithKline ... - Seneca Globe (NASDAQ:TTHI)
www.senecaglobe.com - April 19 at 10:17 AM
nasdaq.com logoTransition: Lilly Not To Advance Diabetes Drug Candidate TT401 To Phase 3 (NASDAQ:TTHI)
www.nasdaq.com - April 18 at 9:57 AM
streetinsider.com logoTransition Therapeutics (TTHI) Says Lilly (LLY) Won't Advance TT401 into Phase 3 (NASDAQ:TTHI)
www.streetinsider.com - April 18 at 9:57 AM
investors.com logoTransition Therapeutics Inc to advance diabetes drug without Eli Lilly (NASDAQ:TTHI)
www.proactiveinvestors.com - April 18 at 9:57 AM
thestreet.com logoTransition Therapeutics Provides Update On Type 2 Diabetes Drug Candidate TT401 (NASDAQ:TTHI)
www.thestreet.com - April 18 at 6:34 AM
News IconMaking Impressive Motion: Transition Therapeutics Inc. (NASDAQ:TTHI), Sumitomo Mitsui Financial Group (NYSE ... - Property Mentor (NASDAQ:TTHI)
www.propertymentorgroup.com - April 14 at 2:14 PM
News IconAfter Last Week What Do Analysts Think Of Transition Therapeutics, Inc. (TTHI) - Share Trading News (NASDAQ:TTHI)
www.sharetrading.news - April 12 at 12:50 PM
News IconTransition Therapeutics, Inc. (TTHI) Updated Broker Price Targets - Share Trading News (NASDAQ:TTHI)
www.sharetrading.news - April 9 at 12:12 PM
News IconTransition Therapeutics, Inc. (TTHI) - Broker Update - Risers & Fallers (NASDAQ:TTHI)
www.risersandfallers.com - April 9 at 12:12 PM
News IconTransition Therapeutics Ord (NASDAQ:TTHI) Short Interest Decreased By 5.4% - Stock Caller (NASDAQ:TTHI)
www.stockcaller.com - April 5 at 2:22 PM
finance.yahoo.com logoTransition Therapeutics Receives Notification From NASDAQ (NASDAQ:TTHI)
finance.yahoo.com - March 17 at 5:01 PM
finance.yahoo.com logoTransition Therapeutics to Present at the 36th Annual Cowen Healthcare Conference (NASDAQ:TTHI)
finance.yahoo.com - March 1 at 4:30 PM
News IconDETROIT — The moon turned blue on Tuesday and a pig was spotted flying near the Ottawa airport (NASDAQ:TTHI)
www.ad-hoc-news.de - February 10 at 12:33 PM
sg.finance.yahoo.com logoTransition Therapeutics posts 2Q loss (NASDAQ:TTHI)
sg.finance.yahoo.com - February 9 at 6:29 PM
finance.yahoo.com logoTransition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results (NASDAQ:TTHI)
finance.yahoo.com - February 9 at 4:30 PM
finance.yahoo.com logoTransition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST (NASDAQ:TTHI)
finance.yahoo.com - February 5 at 1:01 PM
finance.yahoo.com logoTransition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401 (NASDAQ:TTHI)
finance.yahoo.com - February 1 at 6:01 AM
finance.yahoo.com logoTransition Therapeutics Announces Annual General Meeting Voting Results (NASDAQ:TTHI)
finance.yahoo.com - January 6 at 6:01 AM
finance.yahoo.com logoTRANSITION THERAPEUTICS INC. Financials (NASDAQ:TTHI)
finance.yahoo.com - December 8 at 1:15 PM
finance.yahoo.com logoTransition Therapeutics to Host Investor Day November 23 in New York (NASDAQ:TTHI)
finance.yahoo.com - November 19 at 11:45 AM
sg.finance.yahoo.com logoTransition Therapeutics posts 1Q loss (NASDAQ:TTHI)
sg.finance.yahoo.com - November 10 at 4:21 PM
finance.yahoo.com logoTransition Therapeutics Announces First Quarter Fiscal 2016 Financial Results (NASDAQ:TTHI)
finance.yahoo.com - November 10 at 4:01 PM
noodls.com logoAppointment of Non-Executive Director (G Pace) (NASDAQ:TTHI)
www.noodls.com - November 8 at 8:26 PM
finance.yahoo.com logoTransition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST (NASDAQ:TTHI)
finance.yahoo.com - November 2 at 6:01 AM
finance.yahoo.com logoTransition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug Candidate (NASDAQ:TTHI)
finance.yahoo.com - October 29 at 4:01 PM

Social

Transition Therapeutics (NASDAQ:TTHI) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff